ArticlePLoS computational biology2026
Optimized phenotype definitions boost GWAS power.
Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Complex diseases are a major challenge, and genetics underlie a large fraction of the risk for these diseases. Observational data are helpful for this research due to large scale, cost-effectiveness, information on many different conditions, and future scalability, but they reflect factors such as healthcare processes, access to care, and broader societal effects like systemic biases. Here, we introduce MaxGCP, a phenotyping method designed to purify the genetic signal in observational data. MaxGCP optimizes a phenotype definition to maximize its coheritability-the genetic covariance between two traits normalized by their phenotypic standard deviations-with the complex trait of interest. Unlike previous phenotype-combination methods, MaxGCP is phenotype-specific, has linear computational complexity in the number of features, and does not require manual feature selection. In an analysis of stroke, we found that MaxGCP boosts study power by more than 13 percent compared to conventional, single-code phenotype definitions. MaxGCP is a powerful tool for genetic discovery in observational data, and we anticipate that it will be broadly useful for studying complex diseases using observational data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.